Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System?

Structural Insight into the Function of Myelin Basic Protein as a Ligand for Integrin  M 2

(2014) R. Stapulionis et al.   JOURNAL OF IMMUNOLOGY

On the roles of polyvalent binding in immune recognition: Perspectives in the nanoscience of immunology and the immune response to nanomedicines

(2012) Thomas Vorup-Jensen   ADVANCED DRUG DELIVERY REVIEWS

Permeating the Blood Brain Barrier and Abrogating the Inflammation in Stroke: Implications for Stroke Therapy

(2012) Cesar V. Borlongan et al.   CURRENT PHARMACEUTICAL DESIGN

Regulation of inflammasome signaling

(2012) Vijay A K Rathinam et al.   NATURE IMMUNOLOGY

Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars

(2012) Steven A. Berkowitz et al.   NATURE REVIEWS DRUG DISCOVERY

B cells and antibodies in multiple sclerosis pathogenesis and therapy

(2012) Markus Krumbholz et al.   Nature Reviews Neurology

Will the real multiple sclerosis please stand up?

(2012) Peter K. Stys et al.   NATURE REVIEWS NEUROSCIENCE

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

(2012) Gary Bloomgren et al.   NEW ENGLAND JOURNAL OF MEDICINE

Citrullination of Histone H3 Interferes with HP1-Mediated Transcriptional Repression

(2012) Priyanka Sharma et al.   PLoS Genetics

Smoking and Increased Risk of Multiple Sclerosis: Parallel Trends in the Sex Ratio Reinforce the Evidence

(2011) Natalia Palacios et al.   ANNALS OF EPIDEMIOLOGY

Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies

(2011) E. Tavazzi et al.   CLINICAL MICROBIOLOGY AND INFECTION

The effect of IgG levels on the number of natural killer cells and their Fc receptors in chronic inflammatory demyelinating polyradiculoneuropathy

(2011) A. B. Bohn et al.   EUROPEAN JOURNAL OF NEUROLOGY

Metalloproteinase-mediated Shedding of Integrin β2 Promotes Macrophage Efflux from Inflammatory Sites

(2011) Ivan G. Gomez et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Glatiramer Acetate Treatment of Multiple Sclerosis: An Immunological Perspective

(2011) M. K. Racke et al.   JOURNAL OF IMMUNOLOGY

Multiple sclerosis and depression

(2011) Anthony Feinstein   Multiple Sclerosis Journal

Glatiramer acetate antibodies, gene expression and disease activity in multiple sclerosis

(2011) F Sellebjerg et al.   Multiple Sclerosis Journal

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

(2011) Stephen Sawcer et al.   NATURE

Evidence-based guideline update: Plasmapheresis in neurologic disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

(2011) I. Cortese et al.   NEUROLOGY

Glatiramer Acetate Treatment Directly Targets CD11b+ Ly6G− Monocytes and Enhances the Suppression of Autoreactive T cells in Experimental Autoimmune Encephalomyelitis

(2011) A. Toker et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Evidence for a two-stage disability progression in multiple sclerosis

(2010) E. Leray et al.   BRAIN

Failure of glatiramer acetate to modify the peripheral T cell repertoire of relapsing–remitting multiple sclerosis patients

(2010) Laureline Berthelot et al.   CLINICAL IMMUNOLOGY

Contribution of Myelin Autoantigen Citrullination to T Cell Autoaggression in the Central Nervous System

(2010) A. Carrillo-Vico et al.   JOURNAL OF IMMUNOLOGY

Shedding of Large Functionally Active CD11/CD18 Integrin Complexes from Leukocyte Membranes during Synovial Inflammation Distinguishes Three Types of Arthritis through Differential Epitope Exposure

(2010) L. C. Gjelstrup et al.   JOURNAL OF IMMUNOLOGY

HERVs in Neuropathogenesis

(2010) Tove Christensen   Journal of Neuroimmune Pharmacology

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

(2010) C. Ford et al.   Multiple Sclerosis Journal

Multiple Sclerosis: Association with HL-A3

(2010) S. NAITO et al.   TISSUE ANTIGENS

B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis

(2009) Mrinalini Kala et al.   EXPERIMENTAL NEUROLOGY

Sustained release oral fampridine in the treatment of multiple sclerosis

(2009) Norman J Kachuck   EXPERT OPINION ON PHARMACOTHERAPY

T Cell-Mediated Autoimmune Disease Due to Low-Affinity Crossreactivity to Common Microbial Peptides

(2009) Maria Harkiolaki et al.   IMMUNITY

Azathioprine for multiple sclerosis

(2009) I Casetta et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Enhanced Microglial Clearance of Myelin Debris in T Cell-Infiltrated Central Nervous System

(2009) Helle Hvilsted Nielsen et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Lessons learned from the contamination of heparin

(2009) Haiying Liu et al.   NATURAL PRODUCT REPORTS

Ephraim Katchalski-Katzir (1916–2009)

(2009) Michael Eisenbach   TRENDS IN BIOCHEMICAL SCIENCES

Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D

(2009) Sreeram V. Ramagopalan et al.   PLoS Genetics

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET

Environmental factors and multiple sclerosis

(2008) George C Ebers   LANCET NEUROLOGY

Long-term (up to 22 years), open-label, compassionate-use study of glatiramer acetate in relapsing—remitting multiple sclerosis

(2008) Aaron Miller et al.   Multiple Sclerosis Journal

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events

(2008) Marco Guerrini et al.   NATURE BIOTECHNOLOGY

Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis

(2008) Manuel A Friese et al.   NATURE MEDICINE

Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System

(2008) Takashi Kei Kishimoto et al.   NEW ENGLAND JOURNAL OF MEDICINE

Levels of brain related proteins in cerebrospinal fluid: An aid in the differential diagnosis of parkinsonian disorders

(2008) Radu Constantinescu et al.   PARKINSONISM & RELATED DISORDERS

Chromatic discrimination losses in multiple sclerosis patients with and without optic neuritis using the Cambridge Colour Test

(2008) ANA LAURA DE ARAÚJO MOURA et al.   VISUAL NEUROSCIENCE